Research in Community and Public Health Nursing (지역사회간호학회지)

Korean Academy of Community Health Nursing (한국지역사회간호학회)
권호 표지

The hs-CRP Levels and the Metabolic Syndrome according to Glucose Intolerance in Inhabitants of Rural Communities

한 농촌지역 주민들의 혈당장애에 따른 hs-CRP와 대사증후군

  • Kim, Jong-Im (Department of Nursing, Daejeon Health Sciences College)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was to investigate the relations and odds ratio between hs-CRP and the risk factors of metabolic syndrome according to glucose intolerance and diabetes among the residents of a rural community. Methods: The subjects include 1,968 adults aged from 40 to 70 who were divided into four groups and a diabetes group according to glucose intolerance to compare the relations and risk ratio between hs-CRP and the risk factors of metabolic syndrome. Results: The results reveal that the greater the subjects' glucose intolerance was, the higher their hs-CRP became and the more risk factors of metabolic syndrome they had. The impaired glucose tolerance group showed 1.7 times higher blood pressure than the control group. The diabetes group showed a high odds ratio with 2.3 times higher blood pressure, 2.2 times higher abdominal obesity, and 2.4 times higherW/Ht than the control group. And the odds ratio increased significantly by 1.7 times in the hs-CRP intermediate risk group and 2.5 times in the high risk group compared with the control group. Conclusion: Considering the study results, it is very important to monitor abdominal obesity, blood pressure and the intermediate and high risk group of hs-CRP in order to reduce the contraction of cardiovascular diseases.

Keywords

References

  1. American Heart Association. Cholesterol level. Available from http://www.amhrt.org/presenter.jhtml?identifier = 4500
  2. Aronson, D., Bartha, P., Zinder, O., Kemer, A., Shitman, E., & Markiewcz, W. (2004). Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabetic Medicine, 21(1), 39-44 https://doi.org/10.1046/j.1464-5491.2003.01084.x
  3. Barzilay, J. I., Spickerman, C. F., Wahi, P. W., Kuller, L. H., Cushman, M., & Furberg, C. D. (1999). Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet, 354, 622-625 https://doi.org/10.1016/S0140-6736(98)12030-5
  4. Davis, M. J., Raymondm, N. T., Day, J. L., Hales, C. N., & Burden, A. C. (2000). Impaired glucose tolerance and fasting hyperglyccaemia have different characteristics. Diabetic Medicine, 17(6), 433-440 https://doi.org/10.1046/j.1464-5491.2000.00246.x
  5. Elasy, T. (2007). Diabetes and C-reactive protein. Clinical Diabetes, 25(1), 1-2 https://doi.org/10.2337/diaclin.25.1.1
  6. Ford, E. S., Gauska, D. A., Gillespie, C., Will, J. C., Glles, W. H., & Dietz, W. H. (2001). C-reactive protein and body mass index in children: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. The Journal of Pediatrics, 138(4), 486-492 https://doi.org/10.1067/mpd.2001.112898
  7. Freeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., & Lowe, G. D. (2002). C-reactive protein is an indendent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study. Diabetes, 51(5), 1596-1600 https://doi.org/10.2337/diabetes.51.5.1596
  8. Guerrero-Romero, F., & Rodriguez-Moran, M. (2001). Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose. Journal of Diabetes Complications, 15(1), 34-37 https://doi.org/10.1016/S1056-8727(00)00131-8
  9. Gabir, M. M., Hanson, R. I., Diabelea, D., & Imperatore, G. (2000). Roumain vascular disease and mortality: Evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care, 23(8), 1113-1118 https://doi.org/10.2337/diacare.23.8.1113
  10. Genuth, S., Alberti, K. G., Bennett, P., Buse, J., Defronzo, R., & Kahn, R. (2003). Expert Committee on the aiagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26(11), 3160-3167 https://doi.org/10.2337/diacare.26.11.3160
  11. Grundy, S. M., Cleeman, J. L., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17), 2735-2752 https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  12. Hsieh, S. D., & Muto, T. (2006). Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: proposal to use the waist-to-height ratio. Preventive Medicine, 42(2), 135-139 https://doi.org/10.1016/j.ypmed.2005.08.007
  13. Isomaa, B., Almgren, P., Torsen, B., Laht, K., Nissen, M., Taskinen, M. R., et al. (2001). Cardiovascular morbidity and mortality Association with the metabolic syndrome. Diabetes Care, 24(4), 683-689 https://doi.org/10.2337/diacare.24.4.683
  14. KCDC (2005). Korea Centers Disease Control and Prevention.
  15. Klein, R. (2002). Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care, 18(2), 258-268 https://doi.org/10.2337/diacare.18.2.258
  16. KOSSO (2005). Korean Society for The Study of Obesity.
  17. Lin, Y., Rajala, M. W., Berger, J. P., Moller, D. E., Barzilai, N., & Scherr, P. E. (2001). Hyperglycemia-induced production of acute phase reactants in adipose tissue. Journal of Biological Chemistry, 276(9), 42077-42083 https://doi.org/10.1074/jbc.M107101200
  18. Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., & Pio, J. R. (2004). Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united adults. Circulation, 110(10), 1245-1250 https://doi.org/10.1161/01.CIR.0000140677.20606.0E
  19. McNeill, A. M., Rosamond, W. D., Girman, C. K., Golden, S. H., Schmidt, M. L., & East, H. E. (2005). The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 28(2), 385-390 https://doi.org/10.2337/diacare.28.2.385
  20. Nakanishi, N., Shirishi, T., & Wada, M. (2005). Association between fasting glucose and C-reactive protein in a Japanese population the Minoh study. Diabetes Research and Clinical Practice, 69(1), 88-98 https://doi.org/10.1016/j.diabres.2004.11.009
  21. Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O. 3rd., Criqui, M., et al. (2003). Markers of inflamation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation, 107, 499-511 https://doi.org/10.1161/01.CIR.0000052939.59093.45
  22. Pickup, J. C., & Crook, M. A. (1998). Is type II diabetes mellitus a disease of the innate immune system? Diabetologia, 41(10), 1241-1248 https://doi.org/10.1007/s001250051058
  23. Roberts, W. L. (2004). CDC/AHA workshop on markers of inflammation and cardiovascular disease. Application to clinical and public health practice: Laboratory Tests Available to Assess Inflammation? Performance and Standardization: A Background Paper. Circulation, 110, 572-576 https://doi.org/10.1161/01.CIR.0000148986.52696.07
  24. Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003). Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 4719 initially healthy American women. Circulation, 107(3), 391-397 https://doi.org/10.1161/01.CIR.0000055014.62083.05
  25. Ridker, P. M., Wilson, P. W., & Grundy, S. M. (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation, 109, 2818-2825 https://doi.org/10.1161/01.CIR.0000132467.45278.59
  26. Thomas, G. N., Ho, S-Y., Lam, K. S. L., Janus, E. D., Hedley, A. J., & Lam, T. H. (2004). Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obesity Research, 12(11), 1805-1813 https://doi.org/10.1038/oby.2004.224
  27. Thomas, G. N., Schooling, C. M., McGhee, S. M., Ho, S-Y., Cheung, B. M. Y., Wat, N. M., et al. (2006). Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study. European Journal of Endocrinology, 155(4), 623-632 https://doi.org/10.1530/eje.1.02250
  28. Weyer, C., Bogardus, C., & Pratey, R. E. (1999). Metabolic characteristics of individuals with impaired fasting glucose and /or impaired glucose tolerance. Diabetes, 48(11), 2197-2203 https://doi.org/10.2337/diabetes.48.11.2197
  29. WHO. (1999). Diagnosis and classification of diabetes mellitus and classification of diabetes mellitus. Geneva: World Health Organization.
  30. WHO. (2000). The Asia-Pacific perspective: Redefining obesity and its treatment. Sydney, Australia, Health Communications Australia.